An international team of respiratory disease specialists looked back at research in 2017 and assembled a review of the current approaches to asthma and COPD.
Published in the journal Respirology, the authors provide exceptional insight into asthma and COPD research and what pharmacists should know and appreciate about these diseases.
The good news is that estimated global asthma mortality in individuals aged 5 to 34 has improved since 1993. The bad news is those improvements stalled between 2006 and 2012.
With respect to asthma, the authors indicated that researchers and clinicians have a better appreciation of how asthma changes as patients age. Today, we tend to address pediatric and adult asthma somewhat differently.